You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Eczema

Delgocitinib for treating moderate to severe chronic hand eczema [ID6408]

  • In development
  • Reference number: GID-TA11506
  • Expected publication date:  01 October 2025
  • Project information
  • Project documents

On this page

  1. Draft guidance
  2. Declaration of interests
  3. Invitation to participate
  4. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
  5. Topic selection

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Draft consultation document (online commenting)

  • Draft consultation document (downloadable version) (PDF 211 KB)

    Published:
    08 July 2025
  • Committee papers (PDF 6.17 MB)

    Published:
    08 July 2025
  • Public committee slides (PDF 610 KB)

    Published:
    08 July 2025
  • Equality impact assessment (downloadable version) (PDF 114 KB)

    Published:
    08 July 2025

Declaration of interests

  • Register of interests (PDF 96 KB)

    Published:
    18 June 2025

Invitation to participate

  • Final scope (PDF 192 KB)

    Published:
    22 October 2024
  • Final stakeholder list (PDF 179 KB)

    Published:
    22 October 2024
  • Equality impact assessment (scoping) (PDF 136 KB)

    Published:
    22 October 2024
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 357 KB)

    Published:
    22 October 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Draft matrix post referral (PDF 175 KB)

    Published:
    17 July 2024
  • Draft scope post referral (PDF 201 KB)

    Published:
    17 July 2024

Topic selection

  • Topic selection

Back to top